MX359181B - Hidrolizado de colágeno y uso del mismo. - Google Patents
Hidrolizado de colágeno y uso del mismo.Info
- Publication number
- MX359181B MX359181B MX2014006420A MX2014006420A MX359181B MX 359181 B MX359181 B MX 359181B MX 2014006420 A MX2014006420 A MX 2014006420A MX 2014006420 A MX2014006420 A MX 2014006420A MX 359181 B MX359181 B MX 359181B
- Authority
- MX
- Mexico
- Prior art keywords
- collagen hydrolysate
- hydrolysate
- collagen
- treating
- relates
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title abstract 2
- 108010035532 Collagen Proteins 0.000 title abstract 2
- 229920001436 collagen Polymers 0.000 title abstract 2
- 239000000413 hydrolysate Substances 0.000 title abstract 2
- 208000035484 Cellulite Diseases 0.000 abstract 1
- 206010049752 Peau d'orange Diseases 0.000 abstract 1
- 230000036232 cellulite Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Confectionery (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un hidrolizado de colágeno, para usarse como un ingrediente activo en el tratamiento y/o prevención de celulitis, en donde al menos 90% en peso del hidrolizado de colágeno tiene un peso molecular de menos de 3, 500 Da, y de manera preferida al menos 45% en peso del hidrolizado de colágeno tiene un peso molecular de menos de 1, 500 Da.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011055800A DE102011055800A1 (de) | 2011-11-29 | 2011-11-29 | Verwendung von Kollagenhydrolysat |
| DE201210101911 DE102012101911A1 (de) | 2012-03-07 | 2012-03-07 | Verwendung von Kollagenhydrolysat |
| PCT/EP2012/073180 WO2013079373A1 (de) | 2011-11-29 | 2012-11-21 | Kollagenhydrolysat und dessen verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014006420A MX2014006420A (es) | 2014-07-30 |
| MX359181B true MX359181B (es) | 2018-09-17 |
Family
ID=47263289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014006420A MX359181B (es) | 2011-11-29 | 2012-11-21 | Hidrolizado de colágeno y uso del mismo. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140255485A1 (es) |
| EP (1) | EP2785420B1 (es) |
| JP (2) | JP2015504440A (es) |
| CN (1) | CN104010697B (es) |
| AU (1) | AU2012344135B2 (es) |
| BR (1) | BR112014011481B1 (es) |
| CA (1) | CA2854856C (es) |
| ES (1) | ES2669318T3 (es) |
| MX (1) | MX359181B (es) |
| PL (1) | PL2785420T3 (es) |
| RU (1) | RU2635995C2 (es) |
| WO (1) | WO2013079373A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104800094B (zh) * | 2014-01-27 | 2018-03-27 | 上海拜瑞曼克生物科技有限公司 | 一种防妊娠纹腹膜 |
| CL2015000593A1 (es) * | 2015-03-11 | 2016-01-22 | Alfredo Rodríguez Cerda Patricio | Composición cosmética reductiva de aplicación tópica que contiene queratina, azufre, aceite de castor, surfactantes y agua. |
| JP6578323B2 (ja) * | 2017-06-29 | 2019-09-18 | 肇 小座野 | フィラグリン産生促進剤 |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| CN108949885A (zh) * | 2018-08-16 | 2018-12-07 | 东北农业大学 | 一种对成骨细胞增殖具有促进作用的猪皮明胶肽的制备方法及应用 |
| JP7095536B2 (ja) * | 2018-10-01 | 2022-07-05 | ユーハ味覚糖株式会社 | 粘膜保護関連遺伝子発現促進剤およびその用途 |
| DE102018133374A1 (de) * | 2018-12-21 | 2020-06-25 | Gelita Ag | Kollagenhydrolysat zur Verwendung gegen Hautkrankheiten und Darmkrankheiten |
| DE102019130196A1 (de) * | 2019-11-08 | 2021-05-12 | Gelita Ag | Verfahren zur Herstellung von Kollagenpeptiden aus Knochen, und hergestellte Kollagenpeptide |
| CN112056550A (zh) * | 2020-07-27 | 2020-12-11 | 光亚生物科技(广州)有限公司 | 一种滋补活性小分子鹿胶膏及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7318934B2 (en) * | 2002-10-29 | 2008-01-15 | Medical Nutrition Usa, Inc. | Method for treating wounds to promote healing |
| JP2005053798A (ja) * | 2003-08-04 | 2005-03-03 | Nonogawa Shoji Kk | フィブロネクチン生成促進剤 |
| JP5689222B2 (ja) | 2006-11-15 | 2015-03-25 | 株式会社明治 | コラーゲンペプチド組成物及びこれを含有する飲食品 |
| CN101518645A (zh) * | 2008-02-29 | 2009-09-02 | 李勇 | 海洋胶原肽在制备保护肾脏功能、延缓慢性肾衰进程药物、保健食品或食品中的用途 |
| FR2930154B1 (fr) * | 2008-04-21 | 2012-04-20 | Oreal | Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau |
| KR101393403B1 (ko) * | 2008-08-27 | 2014-05-14 | (주)아모레퍼시픽 | 콜라겐 펩티드를 함유하는 피부미용 개선용 조성물 |
| DE102009030351A1 (de) * | 2009-06-22 | 2010-12-23 | Gelita Ag | Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen |
| WO2011011808A1 (en) * | 2009-07-30 | 2011-02-03 | Roman Buga | A cosmetic composition comprising sodium chloride in combination with one or more of protein, collagen, gelatin or amino acid |
| DE102010060564A1 (de) * | 2010-11-15 | 2012-05-16 | Gelita Ag | Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel |
-
2012
- 2012-11-21 CA CA2854856A patent/CA2854856C/en active Active
- 2012-11-21 BR BR112014011481-1A patent/BR112014011481B1/pt active IP Right Grant
- 2012-11-21 AU AU2012344135A patent/AU2012344135B2/en active Active
- 2012-11-21 ES ES12794246.4T patent/ES2669318T3/es active Active
- 2012-11-21 CN CN201280058817.3A patent/CN104010697B/zh active Active
- 2012-11-21 WO PCT/EP2012/073180 patent/WO2013079373A1/de not_active Ceased
- 2012-11-21 JP JP2014543839A patent/JP2015504440A/ja active Pending
- 2012-11-21 EP EP12794246.4A patent/EP2785420B1/de active Active
- 2012-11-21 RU RU2014126216A patent/RU2635995C2/ru active
- 2012-11-21 MX MX2014006420A patent/MX359181B/es active IP Right Grant
- 2012-11-21 PL PL12794246T patent/PL2785420T3/pl unknown
-
2014
- 2014-05-20 US US14/282,239 patent/US20140255485A1/en not_active Abandoned
-
2017
- 2017-12-08 JP JP2017235964A patent/JP6462101B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015504440A (ja) | 2015-02-12 |
| RU2014126216A (ru) | 2016-01-27 |
| PL2785420T3 (pl) | 2018-08-31 |
| BR112014011481A2 (pt) | 2017-05-09 |
| AU2012344135B2 (en) | 2017-01-05 |
| CN104010697A (zh) | 2014-08-27 |
| CA2854856C (en) | 2020-03-10 |
| EP2785420B1 (de) | 2018-03-14 |
| MX2014006420A (es) | 2014-07-30 |
| BR112014011481B1 (pt) | 2019-02-05 |
| WO2013079373A1 (de) | 2013-06-06 |
| JP6462101B2 (ja) | 2019-01-30 |
| JP2018043999A (ja) | 2018-03-22 |
| AU2012344135A1 (en) | 2014-06-26 |
| CA2854856A1 (en) | 2013-06-06 |
| US20140255485A1 (en) | 2014-09-11 |
| RU2635995C2 (ru) | 2017-11-17 |
| ES2669318T3 (es) | 2018-05-24 |
| CN104010697B (zh) | 2017-09-08 |
| EP2785420A1 (de) | 2014-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX359181B (es) | Hidrolizado de colágeno y uso del mismo. | |
| MX2013015311A (es) | Polipeptidos de enlace de pcsk9 y metodos de uso. | |
| MX2014011134A (es) | Compuestos de carbamato y preparacion y uso de los mismos. | |
| MX359327B (es) | Composiciones y sus usos para tratar y prevenir la enfermedad de huntington. | |
| HK1220980A1 (zh) | 用於治疗庞贝氏症的方法和组合物 | |
| JO3343B1 (ar) | أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها | |
| BR112013032229A2 (pt) | método de tratamento hidrocatalítico hidrotérmico de biomassa, e, composição | |
| AU339376S (en) | Sterilizing case | |
| MX2021001169A (es) | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas. | |
| PL2916855T3 (pl) | Hydrolizat kolagenu i jego zastosowanie | |
| SMT201700415T1 (it) | Composizioni di c1-inh per l’uso nella prevenzione e nel trattamento dell’angioedema ereditario (hae) | |
| MX359769B (es) | Metodos para descelularizar huesos. | |
| IN2014CN04014A (es) | ||
| GB2498325A (en) | Modulation neural pathways | |
| EP2897689A4 (en) | COMPOSITIONS AND METHODS OF TREATING ALOPEZIA | |
| IN2014DN08385A (es) | ||
| PH12013501205A1 (en) | Robo1-fc fusion protein for use in the treatment of hepatocarcinoma | |
| IN2014DN11078A (es) | ||
| MX2014009750A (es) | Composiciones antifungicas para el tratamiento de piel y uñas. | |
| IN2014DN00254A (es) | ||
| UA112760C2 (uk) | Теобромін у комбінації з гвайфенезином для лікування кашлю | |
| BR112015002531A2 (pt) | composição, método de tratamento de hipersensibilidade e uso de carbonato de cálcio. | |
| MX2015013755A (es) | Formulacion farmaceutica para uso en el tratamiento y/o prevencion de restenosis. | |
| UA117567C2 (uk) | Композиція, яка стимулює лактацію, на основі фосфатидилсерину | |
| IT1406153B1 (it) | Metodi di prevenzione e terapia per parti e nascite pretermine. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |